21. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancer. (April 2020) Authors: Besse, Benjamin; Garrido, Pilar; Cortot, Alexis B.; Johnson, Melissa; Murakami, Haruyasu; Gazzah, Anas; Gil, Maciej; Bennouna, Jaafar Journal: Lung cancer Issue: Volume 142(2020) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy. Issue 5 (3rd May 2020) Authors: Hulo, Pauline; Coupez, Dahna; Denis, Marc G; Bennouna, Jaafar Journal: Expert review of anticancer therapy Issue: Volume 20:Issue 5(2020) Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial. Issue 2 (February 2021) Authors: Paz-Ares, Luis; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Sakai, Hiroshi; Lingua, Alejo; Salman, Pamela; Souquet, Pierre-Jean; De Marchi, Pedro; Martin... Journal: Lancet oncology Issue: Volume 22:Issue 2(2021) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes. (April 2023) Authors: Reck, Martin; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Cheng, Ying; Sakai, Hiroshi; Paz-Ares, Luis; Lu, Shun; John, Thomas; Sun, Xiaowu; Moisei, Aniel... Journal: European journal of cancer Issue: Volume 183(2023) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial. (July 2019) Authors: Malka, David; François, Eric; Penault-Llorca, Frédérique; Castan, Florence; Bouché, Olivier; Bennouna, Jaafar; Ghiringhelli, François; de la Fouchardière, Christelle; Borg, Christophe; Samalin, Emmanuelle; Bachet, Jean-Baptiste; Raoul, Jean-Luc; Miglianico, Laurent; Bengrine-Lefèvre, Leila; Dahan... Journal: European journal of cancer Issue: Volume 115(2019) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapy. Issue 11 (15th October 2020) Authors: Rana, Suresh; Bennouna, Jaafar; Gutierrez, Alonso N.; Rosenfeld, Anatoly B. Journal: Journal of applied clinical medical physics Issue: Volume 21:Issue 11(2020) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma. Issue 1 (24th June 2020) Authors: Blondy, Thibaut; d'Almeida, Sènan Mickael; Briolay, Tina; Tabiasco, Julie; Meiller, Clément; Chéné, Anne-Laure; Cellerin, Laurent; Deshayes, Sophie; Delneste, Yves; Fonteneau, Jean-François; Boisgerault, Nicolas; Bennouna, Jaafar; Grégoire, Marc; Jean, Didier; Blanquart, Christophe Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer. (8th February 2019) Authors: Kato, Ken; Shah, Manish A; Enzinger, Peter; Bennouna, Jaafar; Shen, Lin; Adenis, Antoine; Sun, Jong-Mu; Cho, Byoung Chul; Özgüroğlu, Mustafa; Kojima, Takashi; Kostorov, Vladimir; Hierro, Cinta; Zhu, Ying; McLean, Lee Anne; Shah, Sukrut; Doi, Toshihiko Journal: Future oncology Issue: Volume 15:Number 10(2019) Page Start: 1057 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicine. (3rd October 2021) Authors: Coupez, Dahna; Hulo, Pauline; Touchefeu, Yann; Denis, Marc G; Bennouna, Jaafar Journal: Expert opinion on biological therapy Issue: Volume 21:Number 10(2021) Page Start: 1325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗